Lower airway microbiota for 'biomarker' measurements of cystic fibrosis disease progression?

Thorax. 2018 Nov;73(11):1001-1003. doi: 10.1136/thoraxjnl-2018-212165. Epub 2018 Aug 22.

Authors

Laura J Sherrard¹, Scott C Bell^{2

3

4}

Affiliations

¹ School of Pharmacy, Queen's University Belfast, Belfast, UK.
² Lung Bacteria Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³ Adult CF Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia.
⁴ Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

PMID: 30135092
DOI: 10.1136/thoraxjnl-2018-212165

No abstract available

Keywords: bacterial infection; cystic fibrosis.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Cystic Fibrosis*
Disease Progression
Humans
Microbiota*
Sputum
Young Adult

Substances

Biomarkers